Michael S. Perry, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 32,500 shares at $61.03 ($2.0M) on 2025-12-05, disclosed to the SEC on 2025-12-09.
Open-market sale of $2.0M ARWR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.03 | 16,250 | $992K | 50.0% |
| 2 | $61.03 | 16,250 | $992K | 50.0% |
| Total | $61.03 avg | 32,500 | $2.0M | 100% |
| Filing → |
| RCEL | SELL | 2022-02-25 | $189K | — | Filing → |
| ARWR | SELL | 2022-01-04 | $460K | — | Filing → |
| RCEL | SELL | 2021-09-07 | $464K | — | Filing → |